Trending stocks

Westbond Enterprises Corp EBITDA surged on 97.5% in 2016 and EBITDA Margin increased on 4.1 pp from 4.7% to 8.8%

21.06.2016 • About Westbond Enterprises Corp ($WBE) • By InTwits

Westbond Enterprises Corp reported FY2016 financial results today. Overall the company's long term financial model is characterised by the following facts:
  • Westbond Enterprises Corp has high CAPEX intensity: 5 year average CAPEX/Revenue was 22.6%. At the same time it's a lot of higher than industry average of 3.1%.
  • CAPEX is quite volatile: 4.6 in FY2016, 2.9 in FY2015, 0.31 in FY2014, 0.15 in FY2013, 0.46 in FY2012
  • The company has potentially unprofitable business model: ROIC is at 2.5%
Below you can find a comprehensive analysis of the key data driving the company's performance and stock price.

Westbond Enterprises Corp ($WBE) key annual financial indicators

mln. CAD201220132014201520162016/2015
P&L
Revenue6.0786.3246.5997.3497.7886.0%
Gross Profit1.2921.3521.3431.3681.4445.6%
SG&A1.1891.2211.3641.243-8.9%
EBITDA0.4420.4800.4540.3480.68797.5%
Net Income0.1240.1210.047-0.4310.053
Balance Sheet
Cash0.0980.0761.6380.0960.11721.6%
Short Term Debt0.5550.3540.0440.3580.51844.6%
Long Term Debt0.0000.0000.0000.2914.5831,476.9%
Cash flow
Capex0.4620.1500.3092.9014.59358.3%
Ratios
Revenue growth-0.1%4.0%4.3%11.4%6.0%
EBITDA growth52.1%8.6%-5.5%-23.2%97.5%
Gross Margin21.2%21.4%20.3%18.6%18.5%-0.1%
EBITDA Margin7.3%7.6%6.9%4.7%8.8%4.1%
Net Income Margin2.0%1.9%0.7%-5.9%0.7%6.5%
SG&A, % of revenue18.8%18.5%18.6%16.0%-2.6%
CAPEX, % of revenue7.6%2.4%4.7%39.5%59.0%19.5%
ROIC4.7%4.0%2.6%0.1%2.5%2.4%
ROE4.2%3.9%1.1%-9.0%1.1%10.1%
Net Debt/EBITDA1.0x0.6x-3.5x1.6x7.3x5.7x


Westbond Enterprises Corp ($WBE) key quoterly financial indicators

mln. CADFY16Q1FY16Q2FY16Q3FY16Q4YoY change
P&L
Revenue22221.9%13.3%7.6%1.7%
EBITDA000046.8%50.0%-14.1%
Net Income000-0
Balance Sheet
Cash0000-91.5%-94.5%-0.7%21.6%
Short Term Debt00011,683.0%-21.2%-31.3%44.6%
Long Term Debt45551,476.9%
Ratios
Gross Margin17.8%19.3%23.3%13.7%0.9%-0.6%5.9%-6.5%
EBITDA Margin 6.4% 7.8% 13.5% 7.5%2.0%1.9%14.0%-1.4%
Net Income Margin 0.4% 3.0% 2.7% -3.5%0.9%17.2%9.8%-1.2%

Revenue and profitability


The company's Revenue increased on 6.0%. Revenue growth showed slow down in FY16Q4 - it was 1.7% YoY. Revenue decline was accompanies by EBITDA margin decline. EBITDA Margin dropped on 33.9 pp from -6.8% to -40.7% in FY2016.

Gross Margin showed almost no change in FY2016. SG&A as a % of Revenue decreased on 2.6 pp from 18.6% to 16.0% in FY2016.

Net Income marign increased on 6.5 pp from -5.9% to 0.68% in FY2016.

Capital expenditures (CAPEX) and working capital investments


In FY2016 Westbond Enterprises Corp had CAPEX/Revenue of 59.0%. CAPEX/Revenue surged on 56.6 pp from 2.4% in FY2013 to 59.0% in FY2016. It's average CAPEX/Revenue for the last three years was 34.4%.Westbond Enterprises Corp investments to CAPEX were large: 668% of EBITDA.

Return on investment


The company operates at low ROIC (2.49%) and ROE (1.13%). ROIC increased on 2.4 pp from 0.071% to 2.5% in FY2016. ROE surged on 10.1 pp from -9.0% to 1.1% in FY2016.

Leverage (Debt)


Company's Net Debt / EBITDA is 7.3x and Debt / EBITDA is 7.4x. Net Debt / EBITDA jumped on 5.7x from 1.6x to 7.3x in FY2016. Debt jumped on 686% while cash surged on 21.6%.

Appendix 1: Peers in Consumer, Non-cyclical


Below you can find Westbond Enterprises Corp benchmarking vs. other companies in Consumer, Non-cyclical industry. It's shown for the period of 5 years for the key financial metrics. Each table has median value for all the companies in the industry together with individual financial data of the top-5 companies in the industry by particular financial metric.

Top companies by Revenue growth, %

Top 5 FY2012 FY2013 FY2014 FY2015 FY2016
Concordia Healthcare Corp ($CXR)159.5%275.7%107.0%
Heritage Global Inc ($HGP)-37.0%76.2%11.2%80.8%
EnerCare Inc ($ECI)8.6%21.1%55.7%76.6%
CRH Medical Corp ($CRH)12.5%56.0%284.2%70.2%
Nuvo Research Inc ($NRI)-25.3%-29.1%57.0%31.9%
 
Median (41 companies)8.6%13.8%15.2%12.8%


Top companies by Gross margin, %

Top 5 FY2012 FY2013 FY2014 FY2015 FY2016
Cipher Pharmaceuticals Inc ($CPH)99.5%98.3%92.7%
Ritchie Bros Auctioneers Inc ($RBA)88.7%88.4%88.0%89.1%88.3%
Information Services Corp ($ISV)77.5%80.4%80.9%87.6%85.1%
Biosyent Inc ($RX)79.3%79.2%78.1%78.7%
Concordia Healthcare Corp ($CXR)79.4%86.0%76.1%72.9%
 
Median (35 companies)32.5%37.1%35.7%35.7%31.1%


Top companies by EBITDA margin, %

Top 5 FY2012 FY2013 FY2014 FY2015 FY2016
CRH Medical Corp ($CRH)21.0%24.5%29.1%44.1%
Valeant Pharmaceuticals International Inc ($VRX)30.6%27.8%45.6%39.8%23.8%
Concordia Healthcare Corp ($CXR)43.7%37.0%39.8%-92.8%
Ritchie Bros Auctioneers Inc ($RBA)36.8%36.3%36.4%39.7%31.4%
EnerCare Inc ($ECI)52.8%51.0%45.5%39.3%26.6%
 
Median (44 companies)9.2%12.4%13.4%11.8%10.1%


Top companies by CAPEX/Revenue, %

Top 5 FY2012 FY2013 FY2014 FY2015 FY2016
ProMetic Life Sciences Inc ($PLI)2.1%33.6%34.6%23.3%
EnerCare Inc ($ECI)25.7%26.5%23.6%20.7%15.5%
Black Diamond Group Ltd ($BDI)61.9%27.5%31.0%17.6%
easyhome Ltd ($EH)32.2%25.6%21.6%16.9%12.7%
K-Bro Linen Inc ($KBL)10.0%19.0%11.4%16.6%
 
Median (43 companies)3.1%2.7%2.3%2.4%2.1%


Top companies by ROIC, %

Top 5 FY2012 FY2013 FY2014 FY2015 FY2016
Information Services Corp ($ISV)71.8%72.8%58.9%38.1%27.6%
Colliers International Group Inc ($CIG)10.5%11.2%15.2%10.9%26.1%
Nuvo Research Inc ($NRI)-11.6%-17.4%-37.9%12.9%20.8%
International Road Dynamics Inc ($IRD)0.9%6.7%4.4%10.6%16.5%
Premium Brands Holdings Corp ($PBH)10.3%9.9%6.9%12.6%15.3%
 
Median (44 companies)8.8%8.4%8.4%6.9%8.0%


Top companies by Net Debt / EBITDA

Top 5 FY2012 FY2013 FY2014 FY2015 FY2016
Concordia Healthcare Corp ($CXR)-1.3x5.6x20.2x
SunOpta Inc ($SOY)2.9x3.5x1.3x16.9x140.8x
Centric Health Corp ($CHH)5.6x10.2x11.2x15.6x
Sienna Senior Living Inc ($SIA)9.5x11.8x9.2x9.1x9.1x
Valeant Pharmaceuticals International Inc ($VRX)9.5x10.4x4.0x7.3x12.7x
 
Median (38 companies)2.8x2.3x3.4x2.5x2.8x